PI3K Pathways Summit 2021
Evvnt Promotion / evvnt
24.08.2021 - 26.08.2021 Online
Time: 9:00 am - 5:00 pm
Temas de la conferencia
With 5 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years.
With 5 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/783356-3?pid=4832
Speakers: Zoe Johnson, Chief Scientific Officer, iOnctura, James Garner, Chief Executive Officer and Managing Director, Kazia Therapeutics and more
Brochure: https://go.evvnt.com/783356-3?pid=4832
Speakers: Zoe Johnson, Chief Scientific Officer, iOnctura, James Garner, Chief Executive Officer and Managing Director, Kazia Therapeutics and more
Información e inscripción:
https://go.evvnt.com/783356-0?pid=4832
Ms. Anita Kelemen
Medicina General, Oncología
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
